$68.85
5.04% today
Nasdaq, Sep 16, 08:17 pm CET
ISIN
US30063P1057
Symbol
EXAS
Sector
Industry

Exact Sciences Corporation Stock price

$65.54
+6.72 11.42% 1M
+4.46 7.30% 6M
-8.44 11.41% YTD
-12.86 16.40% 1Y
-34.14 34.25% 3Y
-41.17 38.58% 5Y
+45.93 234.22% 10Y
Nasdaq, Closing price Fri, Sep 13 2024
-1.85 2.75%
ISIN
US30063P1057
Symbol
EXAS
Sector
Industry

Key metrics

Market capitalization $12.11b
Enterprise Value $13.95b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 5.34
P/S ratio (TTM) P/S ratio 4.64
P/B ratio (TTM) P/B ratio 3.79
Revenue growth (TTM) Revenue growth 13.54%
Revenue (TTM) Revenue $2.61b
EBIT (operating result TTM) EBIT $-281.08m
Free Cash Flow (TTM) Free Cash Flow $-14.96m
Cash position $946.78m
EPS (TTM) EPS $-0.96
P/E forward negative
P/S forward 4.28
EV/Sales forward 4.93
Short interest 7.93%
Show more

Is Exact Sciences Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,912 stocks worldwide.

Exact Sciences Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Exact Sciences Corporation forecast:

21x Buy
88%
3x Hold
13%

Analyst Opinions

24 Analysts have issued a Exact Sciences Corporation forecast:

Buy
88%
Hold
13%

Financial data from Exact Sciences Corporation

Jun '24
+/-
%
Net Profit -175 -175
59% 59%
-7%
Depreciation and Amortization 221 221
1% 1%
8%
Stock Compensation 237 237
15% 15%
9%
Operating Cash Flow 119 119
62% 62%
5%
Investments 134 134
26% 26%
5%
Dividend Paid - -
-
-
Free Cash Flow -15 -15
86% 86%
-1%

In millions USD.

Don't miss a Thing! We will send you all news about Exact Sciences Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Exact Sciences Corporation Stock News

Neutral
Business Wire
about 12 hours ago
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced performance data for its blood-based colorectal cancer (CRC) screening test. Results show sensitivities of 88.3% for CRC and 31.2% for advanced precancerous lesions at specificity of 90.1% for negative samples confirmed by colonoscopy. Results were pr...
Neutral
Seeking Alpha
12 days ago
Exact Sciences Corporation (NASDAQ:EXAS ) Wells Fargo 2024 Healthcare Conference September 5, 2024 3:45 PM ET Company Participants Aaron Bloomer - Chief Financial Officer Conference Call Participants Brandon Couillard - Wells Fargo Brandon Couillard Alright, folks. We'll go ahead and get started.
Neutral
Business Wire
19 days ago
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast. Wells Fargo Healthcare Conference, Boston Fireside chat on Wednesday, September 4, 2024 at 3:45 p.m. ET Baird Global Healthcare Conf...
More Exact Sciences Corporation News

Company Profile

EXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI.

Head office United States
CEO Kevin Conroy
Employees 6,600
Founded 1995
Website www.exactsciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today